Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-04-08 4:10 pm Purchase | 13G | OUTLOOK THERAPEUTICS INC P OTLK | GREAT POINT PARTNERS LLC | 2,231,324 9.99% | 2,231,324 (New Position) | View |
| 2024-02-14 4:39 pm Unchanged | 13G | ZURA BIO LTD ZURA | GREAT POINT PARTNERS LLC | 3,295,000 7.56% | 0 (Unchanged) | View |
| 2024-02-14 4:39 pm Unchanged | 13G | VISTAGEN THERAPEUTICS INC VTGN | GREAT POINT PARTNERS LLC | 2,792,927 9.99% | 0 (Unchanged) | View |
| 2024-02-14 4:38 pm Unchanged | 13G | UROGEN PHARMA LTD URGN | GREAT POINT PARTNERS LLC | 2,620,545 8.49% | 0 (Unchanged) | View |
| 2024-02-14 4:38 pm Purchase | 13G | OPTINOSE INC OPTN | GREAT POINT PARTNERS LLC | 11,484,120 9.99% | 169,401 (+1.50%) | View |
| 2024-02-14 4:37 pm Purchase | 13G | NEUROGENE INC NGNE | GREAT POINT PARTNERS LLC | 994,229 7.75% | 25,000 (+2.58%) | View |
| 2024-02-14 4:37 pm Sale | 13G | HERON THERAPEUTICS INC HRTX | GREAT POINT PARTNERS LLC | 0 0% | -6,360,161 (Position Closed) | View |
| 2024-02-14 4:37 pm Sale | 13G | PRECISION BIOSCIENCES INC DTIL | GREAT POINT PARTNERS LLC | 0 0% | -8,099,799 (Position Closed) | View |
| 2024-02-14 4:36 pm Purchase | 13G | AVALO THERAPEUTICS INC PAR AVTX | GREAT POINT PARTNERS LLC | 2,085 0.26% | 2,085 (New Position) | View |
| 2024-02-14 4:36 pm Purchase | 13G | ALPINE IMMUNE SCIENCES INC ALPN | GREAT POINT PARTNERS LLC | 3,703,433 6.37% | 65,715 (+1.81%) | View |
| 2023-12-27 4:03 pm Purchase | 13G | NEUROGENE INC NGNE | GREAT POINT PARTNERS LLC | 969,229 7.56% | 969,229 (New Position) | View |
| 2023-10-12 4:04 pm Purchase | 13G | VISTAGEN THERAPEUTICS INC VTGN | GREAT POINT PARTNERS LLC | 2,792,927 9.99% | 2,792,927 (New Position) | View |
| 2023-09-15 1:39 pm Purchase | 13G | UROGEN PHARMA LTD URGN | GREAT POINT PARTNERS LLC | 2,620,545 8.51% | 2,620,545 (New Position) | View |
| 2023-06-16 1:31 pm Purchase | 13G | ZURA BIO LTD ZURA | GREAT POINT PARTNERS LLC | 3,295,000 7.65% | 3,295,000 (New Position) | View |
| 2023-04-13 1:58 pm Purchase | 13G | HERON THERAPEUTICS INC HRTX | GREAT POINT PARTNERS LLC | 6,360,161 5.35% | 6,360,161 (New Position) | View |
| 2023-02-27 3:40 pm Purchase | 13G | PRECISION BIOSCIENCES INC DTIL | GREAT POINT PARTNERS LLC | 8,099,799 7.3% | 4,298,494 (+113.08%) | View |
| 2023-02-14 5:00 pm Unchanged | 13G | OPTINOSE INC OPTN | GREAT POINT PARTNERS LLC | 11,314,719 9.99% | 0 (Unchanged) | View |
| 2023-02-14 4:59 pm Sale | 13G | KALVISTA PHARMACEUTICALS INC C KALV | GREAT POINT PARTNERS LLC | 1,055,801 3.1% | -224,199 (-17.52%) | View |
| 2023-02-14 4:58 pm Sale | 13G | 89BIO INC ETNB | GREAT POINT PARTNERS LLC | 700,000 1.37% | -1,400,000 (-66.67%) | View |
| 2023-02-14 4:58 pm Sale | 13G | PRECISION BIOSCIENCES INC DTIL | GREAT POINT PARTNERS LLC | 3,801,305 3.43% | -1,954,091 (-33.95%) | View |